Delcath Systems Inc (DCTH)

Add to Watchlists
Create an Alert
0.1179 -0.00  -3.20% OTC Markets Aug 22, 15:49 Delayed 15m USD
View Full Chart
Price Chart
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • URL:
  • Investor Relations URL:
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Small Cap/Value
  • Next Earnings Release: N/A
  • Last Earnings Release: Aug. 08, 2018
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Delcath Systems Inc is a specialty pharmaceutical and medical device company. It is engaged in the development and commercialization of CHEMOSAT/Melphalan/HDS. The company focuses on the treatment of primary and metastatic liver cancers. Its investigational product Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS) is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.



Excel Add-In Codes

  • Name: =YCI("DCTH","name")
  • Description: =YCI("DCTH","description")
  • Sector: =YCI("DCTH","sector")
  • Industry: =YCI("DCTH","industry")
  • Est. Current Fiscal Year End: =YCI("DCTH","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.